Through its five product groups – Trauma, Spine, Craniomaxillofacial (CMF), Biomaterials and Power Tools – Synthes Inc develops and manufactures instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues, including both metallic and osteobiological materials. The group also has a Veterinary business.
SynthesTrauma - produces plate and screw systems, intramedullary nailing systems and external fixation devices that are used for the surgical treatment of fractures, deformities and tumour diseases of long bones. The company also produces trauma implants for the shoulder, hand, pelvis, hip, condyles and foot.
Synthes Spine - covers products for the treatment of degenerative instabilities, fractures, tumours and deformities. The company offers a full range of solutions for the cervical, thoracic and lumbar spine.
CMF - offers a range of facial trauma, tumour resection and reconstructive implants and instruments.
SynthesBiomaterials - includes a paste that can be used to fill bony defects; an implant for young children that reabsorbs after the body’s bones have healed; and demineralised human bone that promotes bone healing. In May 2011, Synthes sold the Norian assets of its Biomaterials division to Kensey Nash.
Synthes Power Tools - offers a range of air- and battery-driven drill systems, reamers and saws for use in orthopaedics and trauma surgery. In November 2010, this business was expanded with the acquisition of Anspach, which provided a complementary high-speed product line to the Synthes power tools portfolio.
Synthes is the world leader in traumatology, ranks among the top companies for spinal devices and is in the leading position in the CMF business.
In 2011, Synthes generated revenues of nearly US$4 billion and net earnings of US$966 million. The company employs more than 12,000 people, mainly in the US, Switzerland, Germany, Austria and China. Synthes Inc is registered in Delaware, US. Its holding company, Synthes GmbH, is based in Switzerland.
TheSynthesMedical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.
Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reportshave been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.
Evaluate competitive threats
Maximise product and market opportunities
Identify collaborators and strategic partners
Understand the operating market environment
Benchmark your performance against competitors
Key contact information
Introduction to Synthes and its current activities
Summary of its financial performance
Key recent events in an “at a glance” format
The company’s aims and its areas of focus
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)